Global Sterile Self-Destructing Fixed-Dose Vaccine Syringe Market Growth 2025-2031
Description
The global Sterile Self-Destructing Fixed-Dose Vaccine Syringe market size is predicted to grow from US$ 826 million in 2025 to US$ 1125 million in 2031; it is expected to grow at a CAGR of 5.3% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Sterile self-destructive fixed-dose vaccine syringe is a disposable medical device designed for vaccination. Its core structure consists of a polypropylene jacket, a stainless steel needle tube and a self-destruct mechanism (such as a buckle or steel clamp device). It is sterilized by ethylene oxide to ensure sterility. After use, the syringe needle or parts cannot be restored due to mechanical locking to prevent repeated use to avoid cross infection. This product complies with YY/T 0573.3-2019 industry standard, suitable for the precise injection of influenza, new crown and other vaccines, combined with the Chinese safety syringe industry's production of 2.47 billion units in 2024 (of which vaccine syringes account for about 30%-40%), exports of more than 500 million units and the growth in global vaccination demand (such as increased market penetration in Africa and Southeast Asia), and referring to the Chinese safety syringe market size of 524 million yuan (about 73 million US dollars) in 2023 and an annual growth rate of 15%-20%, the global sterile self-destructive fixed-dose vaccine syringe market size in 2024 is expected to be in the range of US$800 million to US$1.2 billion. In the next three years, it will benefit from the increase in global vaccination coverage (especially childhood immunization programs), the demand for emergency reserves for public health events and the iteration of biodegradable material technology, and is expected to exceed US$1.5 billion in 2031.
United States market for Sterile Self-Destructing Fixed-Dose Vaccine Syringe is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Sterile Self-Destructing Fixed-Dose Vaccine Syringe is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Sterile Self-Destructing Fixed-Dose Vaccine Syringe is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Sterile Self-Destructing Fixed-Dose Vaccine Syringe players cover Revital Healthcare, Weigao Group, Sanxin Medical, Shandong Ande Medical Supplies, Shengguang Medical Products, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Sterile Self-Destructing Fixed-Dose Vaccine Syringe Industry Forecast” looks at past sales and reviews total world Sterile Self-Destructing Fixed-Dose Vaccine Syringe sales in 2024, providing a comprehensive analysis by region and market sector of projected Sterile Self-Destructing Fixed-Dose Vaccine Syringe sales for 2025 through 2031. With Sterile Self-Destructing Fixed-Dose Vaccine Syringe sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Sterile Self-Destructing Fixed-Dose Vaccine Syringe industry.
This Insight Report provides a comprehensive analysis of the global Sterile Self-Destructing Fixed-Dose Vaccine Syringe landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Sterile Self-Destructing Fixed-Dose Vaccine Syringe portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Sterile Self-Destructing Fixed-Dose Vaccine Syringe market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Sterile Self-Destructing Fixed-Dose Vaccine Syringe and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Sterile Self-Destructing Fixed-Dose Vaccine Syringe.
This report presents a comprehensive overview, market shares, and growth opportunities of Sterile Self-Destructing Fixed-Dose Vaccine Syringe market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Disposable Type
Durable Type
Segmentation by Application:
Hospitals
Clinics
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Revital Healthcare
Weigao Group
Sanxin Medical
Shandong Ande Medical Supplies
Shengguang Medical Products
Guangdong Haiou Medical Devices
Zhejiang Kangdelai Medical Devices
Key Questions Addressed in this Report
What is the 10-year outlook for the global Sterile Self-Destructing Fixed-Dose Vaccine Syringe market?
What factors are driving Sterile Self-Destructing Fixed-Dose Vaccine Syringe market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Sterile Self-Destructing Fixed-Dose Vaccine Syringe market opportunities vary by end market size?
How does Sterile Self-Destructing Fixed-Dose Vaccine Syringe break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Sterile self-destructive fixed-dose vaccine syringe is a disposable medical device designed for vaccination. Its core structure consists of a polypropylene jacket, a stainless steel needle tube and a self-destruct mechanism (such as a buckle or steel clamp device). It is sterilized by ethylene oxide to ensure sterility. After use, the syringe needle or parts cannot be restored due to mechanical locking to prevent repeated use to avoid cross infection. This product complies with YY/T 0573.3-2019 industry standard, suitable for the precise injection of influenza, new crown and other vaccines, combined with the Chinese safety syringe industry's production of 2.47 billion units in 2024 (of which vaccine syringes account for about 30%-40%), exports of more than 500 million units and the growth in global vaccination demand (such as increased market penetration in Africa and Southeast Asia), and referring to the Chinese safety syringe market size of 524 million yuan (about 73 million US dollars) in 2023 and an annual growth rate of 15%-20%, the global sterile self-destructive fixed-dose vaccine syringe market size in 2024 is expected to be in the range of US$800 million to US$1.2 billion. In the next three years, it will benefit from the increase in global vaccination coverage (especially childhood immunization programs), the demand for emergency reserves for public health events and the iteration of biodegradable material technology, and is expected to exceed US$1.5 billion in 2031.
United States market for Sterile Self-Destructing Fixed-Dose Vaccine Syringe is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Sterile Self-Destructing Fixed-Dose Vaccine Syringe is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Sterile Self-Destructing Fixed-Dose Vaccine Syringe is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Sterile Self-Destructing Fixed-Dose Vaccine Syringe players cover Revital Healthcare, Weigao Group, Sanxin Medical, Shandong Ande Medical Supplies, Shengguang Medical Products, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Sterile Self-Destructing Fixed-Dose Vaccine Syringe Industry Forecast” looks at past sales and reviews total world Sterile Self-Destructing Fixed-Dose Vaccine Syringe sales in 2024, providing a comprehensive analysis by region and market sector of projected Sterile Self-Destructing Fixed-Dose Vaccine Syringe sales for 2025 through 2031. With Sterile Self-Destructing Fixed-Dose Vaccine Syringe sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Sterile Self-Destructing Fixed-Dose Vaccine Syringe industry.
This Insight Report provides a comprehensive analysis of the global Sterile Self-Destructing Fixed-Dose Vaccine Syringe landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Sterile Self-Destructing Fixed-Dose Vaccine Syringe portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Sterile Self-Destructing Fixed-Dose Vaccine Syringe market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Sterile Self-Destructing Fixed-Dose Vaccine Syringe and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Sterile Self-Destructing Fixed-Dose Vaccine Syringe.
This report presents a comprehensive overview, market shares, and growth opportunities of Sterile Self-Destructing Fixed-Dose Vaccine Syringe market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Disposable Type
Durable Type
Segmentation by Application:
Hospitals
Clinics
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Revital Healthcare
Weigao Group
Sanxin Medical
Shandong Ande Medical Supplies
Shengguang Medical Products
Guangdong Haiou Medical Devices
Zhejiang Kangdelai Medical Devices
Key Questions Addressed in this Report
What is the 10-year outlook for the global Sterile Self-Destructing Fixed-Dose Vaccine Syringe market?
What factors are driving Sterile Self-Destructing Fixed-Dose Vaccine Syringe market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Sterile Self-Destructing Fixed-Dose Vaccine Syringe market opportunities vary by end market size?
How does Sterile Self-Destructing Fixed-Dose Vaccine Syringe break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
93 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Sterile Self-Destructing Fixed-Dose Vaccine Syringe by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Sterile Self-Destructing Fixed-Dose Vaccine Syringe by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
